Efficacy of neurofeedback-assisted mindfulness for anxiety and nomophobia in Spanish young adults: a randomized controlled trial
Abstract
Background: Problematic use of new technologies has been associated with anxiety and other disorders in young adults. This study evaluated the efficacy of a Neurofeedback-Assisted Mindfulness Training Program (NAMTP) in reducing anxiety and related symptoms in young adults.
Methods: A randomized clinical trial assigned participants to an intervention group (IG), receiving 20-25 NAMTP sessions, or a control group (CG). All participants received a brief workshop on responsible technology use. Anxiety was assessed using the DASS-21 anxiety subscale. Secondary outcomes included the Smartphone Addiction Scale-Short Version (SAS-SV), Nomophobia Questionnaire (NMP-Q), and Athens Insomnia Scale (AIS), all evaluated at baseline and three months.
Results: A total of 40 participants completed the study (82.5% women; mean age 24.8 ± 3.4). No statistically significant differences were observed between the intervention group (IG) and the control group (CG) in any of the psychological variables assessed. For the DASS scales, the mean differences (IG-CG) were 0.1 (95% CI: -1.6 to 1.9; p = 0.868) for anxiety, -2.4 (95% CI: -7.2 to 2.4; p = 0.324) for depression, and -1.5 (95% CI: -5.3 to 2.4; p = 0.453) for stress. Similarly, the mean difference in the SAS-SV score was -1.0 (95% CI: -5.0 to 2.9; p = 0.606), while for the NMP-Q score it was 3.7 (95% CI: -8.9 to 16.4; p = 0.553). Finally, the Athens Insomnia score showed a mean difference of -1.1 (95% CI: -2.9 to 0.7; p = 0.211). Adherence to…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 40 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.